Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB1148 for Post-Operative Ileus and Adhesions
NCT02836470Phase 2Completed
- Sponsor
- Palisade Bio
- Start
- Oct 2019
- Primary completion
- Sep 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of LB1148 in postoperative ileus (POI), tissue adhesions, sponsored by Palisade Bio. Started Oct 2019; status: completed.
02
Drugs
LB1148
03
Conditions
postoperative ileus (POI)tissue adhesions
Beyond the preview
Go deeper on NCT02836470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836470.